Common genetic variations spread across five genes raise a person's risk of developing the most frequent type of brain tumor, an international research team reports online in Nature Genetics.
Genetic risk factors identified by the research team, led by scientists at The University of Texas M. D. Anderson Cancer Center and the Institute of Cancer Research in the United Kingdom, also are the first glioma risk factors of any type identified in a large study.
"This is a ground-breaking study because it's the first time we've had a large enough sample to understand the genetic risk factors related to glioma, which opens the door to understanding a possible cause of these brain tumors," said co-senior author Melissa Bondy, Ph.D., professor in M. D. Anderson's Department of Epidemiology.
Bondy and colleagues expect their findings eventually to help identify people most at risk for the disease and to provide potential targets for treatment or prevention.
Gliomas, deadly tumors that form in the supportive tissue of the brain and spine, account for about 80 percent of all primary malignant brain tumors, with about 22,000 new cases annually in the United States and 13,000 deaths. They include astrocytomas, oligodendrogliomas and glioblastoma multiforme, the most aggressive, deadly and common glioma in adults.
Risk rises with each variation
Additional research is needed on the genes involved and how variation affects their function and contributes to development of gliomas. And the disease is not solely genetic. A more comprehensive model that includes demographic and behavioral factors and environmental exposures will be needed to identify those at risk.
Bondy will be principal investigator on a multi-center research project that will examine the complex interplay of all of those factors in 6,000 glioma patients and 6,000 controls beginning next year. "We will be able to look at all of the potential risk and protective factors we've identified in much smaller studies over the years, such as exposure to ionizing radiation, allergies, infections, and use of non-steroidal anti-inflammatory drugs, in a much larger study that will include the genes involved," Bondy said.
Combing through 521,571 variations to find 14
Researchers from M. D. Anderson and the Institute of Cancer Research analyzed 521,571 single nucleotide polymorphisms (SNPS) - points in the genome known to commonly vary from person to person - in 1,878 glioma patients and 3,670 controls. They discovered 34 SNPS with evidence of association with glioma.
These 34 were then analyzed in independent case-control studies in Germany, France and Sweden that examined 2,545 cases of glioma and 2,973 controls. The combined analysis winnowed the candidates down to 14 SNPS that mapped to five addresses in the genome.
The five genes identified, listed in descending order by their strongest effect, are:
CCDC26, located on chromosome 8, modulates retinoic acid, which in turn increases programmed cell death in glioblastoma cells and reduces telomerase activity (see next).
TERT, found on chromosome 5, is essential for telomerase activity that preserves telomeres, which are found on the ends of chromosomes and prevent them from unraveling. TERT expression in tumors has been associated with tumor grade and prognosis.
CDKN2A, located on chromosome 9, regulates p14, which activates the tumor-suppressor p53. It also regulates cyclin-dependent kinases vital to the cell cycle. At least one copy of the gene is deleted in half of brain tumors, and loss of CDKN2A expression is associated with poor prognosis.
RTEL1, found on chromosome 20, maintains genomic stability. Its chromosomal address is amplified in 30 percent of gliomas.
PHLDB1, on chromosome 11, is commonly deleted in neuroblastoma but there is no evidence to date of a role for the gene in glioma.
The fact that four of the genetic variations found in a person's genome point to a gene that has been associated in some way with the genome of the tumors is an encouraging sign, Shete said.
"I've been collecting families and case studies since the early 90s," Bondy said. "We have only just begun to understand the causes of brain tumors. Our findings give reasons for hope for those who might be affected and an incentive for a more comprehensive investigation of what has been a mysterious disorder."
The Wellcome Trust provided principal funding for the study. Additional sources include Cancer Research UK, the European Union, grants from the U.S. National Cancer Institute, the American Brain Tumor Association and the National Brain Tumor Society.
Co-authors with Bondy and Shete are co-senior author Richard Houlston and co-first author Fay Hoskings, Lindsay B Robertson, Sara E Dobbins, and Amy Price, all of Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey. U.K.; Georgina Armstrong, Yanhong Liu, and Xiangjun Gu of M. D. Anderson's Department of Epidemiology; Marc Sanson, Yannick Marie, Blandine Boisselier, Jean-Yves Delattre, Khe Hoang-Xuan, Soufiane El Hallani and Ahmed Idbaih, all of Service de Neurologie Mazarin et INSERM, Hôpital de la Salpêtrière in Paris; Beatrice Malmer, Ulrika Andersson and Roger Henriksson, of Department of Radiation Sciences, Oncology, Umeå University, Sweden; Matthias Simon and Johannes Schramm of Neurochirurgische Universitätsklinik, Bonn, Germany; Diana Zelenika and Mark Lathrop of Centre National de Génotypage, Evry Cedex, France; Lathrop also is affiliated with Foundation Jean Dausett-CEPH, Paris; A Tommy Bergenheim, and Anders Ahlbom of Department of Clinical Neuroscience, Umeå University, Sweden; Maria Feychting of Institute of Environmental Medicine, Karolinska Institutet, Sweden; Stefan Lönn of the Department of Medical Epidemiology and Biostatistics Karolinska Institutet, Sweden; Michael Linnebank of the Department of Neurology, University Hospital Zurich, Switzerland; Kari Hemminki and Rajiv Kumar both of the Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany; Sarah Hepworth of Centre for Epidemiology and Biostatistics, Faculty of Medicine and Health, University of Leeds, UK; Kenneth Muir of the Division of Epidemiology and Public Health, University of Nottingham Medical School, Queen's Medical Centre, Nottingham, UK; Minouk Schoemaker Section of Epidemiology, Institute of Cancer Research, Sutton, UK; and Ching Lau of Texas Children's Cancer Center, Baylor College of Medicine, Houston.
About M. D. Anderson
The University of Texas M. D. Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. M. D. Anderson is one of only 40 comprehensive cancer centers designated by the National Cancer Institute. For four of the past six years, including 2008, M. D. Anderson has ranked No. 1 in cancer care in "America's Best Hospitals," a survey published annually in U.S. News & World Report.
Scott Merville | EurekAlert!
Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs
16.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Cholera bacteria infect more effectively with a simple twist of shape
13.01.2017 | Princeton University
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.
The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...
UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration
"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...
Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.
Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
16.01.2017 | Power and Electrical Engineering
16.01.2017 | Information Technology
16.01.2017 | Power and Electrical Engineering